Skip to main content
. Author manuscript; available in PMC: 2015 Mar 25.
Published in final edited form as: Crit Care Med. 2012 Apr;40(4):1291–1296. doi: 10.1097/CCM.0b013e31823da96d

Figure 1.

Figure 1

A, Mortality was 15.3% and 9.8% in the subarachnoid hemorrhage (SAH) group and SAH + hydrogen (H2) group (p > .05, Fisher’s exact test). B, Similar severity of SAH bleeding was obtained in the SAH group (n = 27) and SAH + H2 group (n = 31, p > .05). C, Hydrogen gas (SAH + H2) alleviated neurologic dysfunction (p < .05 vs. SAH) at 24 hrs, whereas the improvement of neurobehavioral score at 72 hrs was not significant (p > .05 vs. SAH). D, This graph shows the body weight loss after SAH. No significant improvement was detected between the SAH group and SAH + H2 group at either 24 (p > .05) or 72 hrs (p > .05). At 24 hrs, sham: n = 27, SAH: n = 27, SAH + H2: n = 31; at 72 hrs, n = 6 in all groups. *p < .05 vs. sham, †p < .05 vs. SAH.